MMJ Recs

NOVEMBER 20, 2023

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Project CBD

FEBRUARY 27, 2023

But there’s another option that can address mood, pain, and more at once, all with fewer side effects: cannabis. Nor is it necessarily surprising, given the ability of cannabis to target the ubiquitous, homeostasis-seeking endocannabinoid system. It’s not a new idea.

THC 144

THC CBD Sleep Clinical Trials 144

Project CBD

MAY 3, 2023

This transcript is adapted from CannMed’s weekly podcast , hosted by Ben Amirault, who recently interviewed Bonni Goldstein, MD, one of the country’s most respected and experienced medical cannabis physicians. Dr. Goldstein has treated thousands of patients with medical cannabis. CBG is not intoxicating or impairing.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. Because cannabis is still a schedule 1 drug in the U.S., clinical research is extremely difficult to conduct. So far, science is telling us that yes cannabis has anti-seizure actions.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

United Patients Group

JANUARY 8, 2023

Cannabis and the Immune System. Cannabis and the Immune System. In fact, cannabis has been used for thousands of years as a medicine. Cannabis has also been used for centuries to treat gastrointestinal disorders, epilepsy, rheumatism and malaria. Immune System and Sleep Deprivation. Introduction.

Blood Pressure 108

Blood Pressure Sleep Cannabinoids Clinical Trials 108

The Cannigma

OCTOBER 11, 2021

The majority of people who use the cannabinoid cannabigerol (CBG) for medical reasons find it to be helpful or very helpful in treating a variety of health conditions, according to the findings of a recent survey. No clinical trial was used in the compilation of the study. Why is CBG ‘the mother of all cannabinoids?’.

Conditions 132

Conditions Clinical Trials Chronic Pain Cannabinoids 132

Canna Care Docs

OCTOBER 3, 2023

Natural plant therapy , and cannabis specifically, has been studied for its effectiveness in alleviating and treating many of these physiological and emotional symptoms that come into play with a terminal illness. However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

AUGUST 28, 2022

Cannabinoids are a class of chemical compounds found in the cannabis plant. There are over 100 cannabinoids, and they are responsible for the plant’s therapeutic effects. Cannabinoids interact with our body’s endocannabinoid system, which regulates many important functions, including mood, appetite, and pain.

Cannabinoids 52

Cannabinoids Trichome Treatment Clinical Trials 52

Cannabis Law Report

AUGUST 19, 2021

Legal cannabis consumption and it isn’t even legal yet. If and when cannabis is actually properly regulated we’re sure the UK can be a world beater!! Cannabidiol or CBD, which is most commonly sold as oil at high street retailers, is one of the active ingredients of non-psychoactive cannabis.

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105

The Cannigma

MARCH 7, 2022

So much attention is placed upon THC and CBD that sometimes the less abundant cannabinoids are forgotten about or not appreciated fully. Yet cannabinol (CBN), the first cannabinoid ever discovered by modern scientists, is slowly making a comeback in the cannabis industry. . The best online schools for medical cannabis training.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. Furthermore, ongoing clinical trials are investigating CBD’s efficacy in treating conditions such as multiple sclerosis, Parkinson’s disease, and substance abuse disorders.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

MMJ Recs

DECEMBER 28, 2023

As the medical community delves into the therapeutic potential of cannabis, certain health conditions have emerged as primary candidates for its prescription. Cannabinoids, the active compounds in marijuana, interact with the endocannabinoid system in the body, modulating pain perception and inflammation.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Cannabis Law Report

MAY 10, 2022

First comprehensive study reveals why Australians take medicinal cannabis. First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions. Medicinal cannabis as a last resort.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. Because cannabis is still a schedule 1 drug in the U.S., clinical research is extremely difficult to conduct. So far, science is telling us that yes cannabis has anti-seizure actions.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Cannabis Law Report

JANUARY 11, 2022

DENVER–(BUSINESS WIRE)– Ripple , Colorado’s trusted cannabis edibles brand and pioneer of fast-acting and clinically proven technology, is leading the way in cannabis wellness with new Ripple Sleep QuickDissolves and Ripple Sleep QuickGummies. faster), and Ripple Dissolvables (1.9X

THC 52

THC Clinical Trials Research and Development Sleep 52

CannaMD

SEPTEMBER 28, 2020

As if those weren’t enough, the fear of the virus alone can also wreak havoc on sleep patterns. Patients around the world are reporting a sharp increase in sleep problems, and physicians have coined the term coronasomnia to describe the phenomenon. A team of researchers is studying the coronavirus-era sleep crisis.

Sleep 72

Sleep Clinical Trials Patients THC 72

TheAnswerPage

FEBRUARY 23, 2022

Some clinical studies have evaluated the safety and efficacy of cannabinoid-based medicines for the treatment of autism spectrum disorder (ASD). What are the common adverse events noted in clinical trials examining the efficacy of cannabinoids for ASD? Fletcher S. Fletcher S. Child: care, health and development.

Clinical Trials 52

Clinical Trials Events Therapy Sleep 52

Cannabis Law Report

JUNE 30, 2021

-1000s of UK athletes regularly taking CBD to manage pain, sleep disorders and anxiety – -Football, Rugby, Cricket, Hockey and Golf stars want clarity from governing bodies-. -UK UK sport has opportunity to lead the world-.

Medicine 75

Medicine Clinical Trials CBD Sleep 75

LifeCannMD

AUGUST 23, 2021

A full night’s sleep is integral to overall health and wellbeing. Seven to nine hours of uninterrupted sleep is recommended each night. The optimum amount of sleep not only ensures rest but also enough energy for the next day. According to studies, as many as 70% of Americans report not being able to sleep the recommended hours.

CBD 52

CBD Sleep Clinical Trials Cannabinoids 52

Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. The researchers’ analysis found anxiety was the reason given for 16% of medicinal cannabis prescriptions. of prescriptions were for sleep disorders. The Guardian writes.

Medicine 52

Medicine Clinical Trials Data Sleep 52

The Joint Blog

MARCH 18, 2021

According to a new study titled Use of cannabinoids for the treatment of patients with post-traumatic stress disorder, the consumption of cannabinoids and cannabinoid products is safe and effective in the mitigation of symptoms of post-traumatic stress (PTS). Additional information on cannabis and PTSD is available from NORML.

Cannabinoids 26

Cannabinoids Patients Clinical Trials Research and Development 26

The Cannigma

MARCH 18, 2021

The majority of people with Parkinson’s disease in the United States have not used cannabis to treat their symptoms due to a lack of scientific evidence about its effectiveness. Of those who have used cannabis, most did not receive a recommendation from a doctor or instructions on how to use it, according to the findings of a recent study.

Patients 138

Patients Clinical Trials Treatment Cannabis 138

Cannabis Law Report

FEBRUARY 2, 2022

UK website Leafie writes… The findings of a study published in JAMA Psychiatry have revealed that road testing for cannabis impairment may be putting up to 1.4m medical cannabis users at risk of unfair prosecution, according to a report by Volteface. Further simulator tests were given at 30 minutes, 1.5, hours after smoking.

Medicine 52

Medicine Clinical Trials Consumption Sleep 52

Project CBD

NOVEMBER 11, 2023

NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

LifeCannMD

FEBRUARY 27, 2024

This shift towards cannabis-based therapies is reshaping the landscape of Crohn’s management, offering new hope and improved quality of life for patients who have long struggled with the disease’s debilitating symptoms. Cannabis has analgesic properties that help alleviate abdominal cramps and discomfort.

Marijuana 59

Marijuana Clinical Trials Treatment Therapy 59

Cannabis Law Report

JULY 28, 2021

The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable Clinical Trials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinical trials in the areas of psychedelics and nutraceuticals, among other substances of study.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Otherside Farms

JULY 8, 2020

With over 100 potent cannabinoids that constitute the Cannabis plant, the possibilities of health benefits are ample. The growth in the cannabis industry has promoted interest among users of several segments to understand how it can make their lives better. Aids with Sleep. Aids in Pain Management.

Marijuana 105

Marijuana Sleep Clinical Trials Events 105

MMJ Recs

NOVEMBER 30, 2023

Medical Marijuana for Epilepsy Treatment Medical marijuana, often referred to as MMJ, is a term used to describe the use of cannabis and its derivatives for therapeutic purposes. The two most well-known compounds in cannabis are tetrahydrocannabinol (THC) and cannabidiol (CBD), each of which has distinct effects on the human body.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

Cannabis Law Report

OCTOBER 12, 2021

Diamandis joins Radicle Science as the healthtech company accelerates growth with industry veteran Sheldon Borkin PhD as CTO, the launch of a first of its kind real-world sleep study, and updates on significant milestones this year. Radicle Real World Sleep results will be announced in early 2022. “We

Clinical Trials 52

Clinical Trials Research and Development Sleep Cannabinoids 52

Veriheal

OCTOBER 13, 2020

Both IBD and IBS have a major impact on the quality of life and on the ability to do simple things such as eat, sleep, and work. Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? . Cannabis for GI Pathologies . What is IBD?

Digestion 123

Digestion Treatment Conditions Research and Development 123

FloridaMarijuana.net

AUGUST 15, 2018

Additionally, the ACPA reported on a clinical trial that suggests that inhaled cannabis may provide short-term relief from Neuropathy. For centuries, humans have relied on the cannabis plant for its therapeutic properties. The endocannabinoid system consists of cannabinoid receptors all over the body.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

Veriheal

MAY 3, 2022

Cannabis use disorder (CUD) is often confused with frequent cannabis use , but CUD is significantly more worrisome. The outcomes and measures used throughout the trial included changes in CUD symptoms; anxiety and depressive symptoms; pain severity; and insomnia symptoms. Clinical Trial Sample Size.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

FloridaMarijuana.net

AUGUST 9, 2018

Other symptoms of mild TBI include headache, confusion, lightheadedness, dizziness, blurred vision or tired eyes, ringing in the ears, bad taste in the mouth, fatigue or lethargy, a change in sleep patterns, behavioral or mood changes, and trouble with memory, concentration, attention, or thinking.

Marijuana 190

Marijuana Patients Clinical Trials Treatment 190

Project CBD

FEBRUARY 28, 2023

The combined total from both channels — $58,293,034 — does not include CBD sales in licensed cannabis dispensaries or CBD products, such as vapes, tinctures, gummies, and other edibles sold online. (E-commerce According to the FDA, “hemp” is defined as Cannabis sativa with a tetrahydrocannabinol (THC) concentration of 0.3%

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

SEPTEMBER 14, 2021

A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”. The OBX and Radicle Science shared values centered around quality, science, and rigor make this a natural alliance to launch a greater movement in the community.”.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

JULY 8, 2021

Seeks To Identify Novel Cannabinoids For Therapeutic Use. Following the execution of this work, cbdMD Therapeutics will perform the requisite toxicological studies with Ion Tox, a leading in vitro toxicology and ADME-PK testing company, to support the safety of the cannabinoids of interest. CHARLOTTE, N.C.–(BUSINESS

Research and Development 111

Research and Development Pets Cannabinoids eCommerce 111

Cannabis Law Report

AUGUST 2, 2021

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105